Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Locycare Nail Gel for Nail Surface Abnormalities
NCT02582762Phase 3Unknown
- Sponsor
- Mahidol University
- Start
- Sep 2015
- Primary completion
- Mar 2016
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of Locycare in nail diseases (onychosis), sponsored by Mahidol University. Primary endpoint: Improvement overall nail surface abnormalities at 8 weeks. Status: unknown.
02
Drugs
Locycare
03
Conditions
nail diseases (onychosis)
Beyond the preview
Go deeper on NCT02582762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02582762.